Radhika Patel Selected Research

3- ((1- (dimethylamino)propan- 2- yl)oxy)- 5- ((4- methoxy- 5- (1- methyl- 1H- pyrazol- 4- yl)pyridin- 2- yl)amino)pyrazine- 2- carbonitrile

1/2017	An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.
1/2016	CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Radhika Patel Research Topics

Disease

5	Neoplasms (Cancer) 12/2021 - 01/2016
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017 - 01/2016
2	Squamous Cell Carcinoma of Head and Neck 01/2017 - 01/2016
1	Inflammation (Inflammations) 01/2022
1	Optic Nerve Diseases (Optic Neuropathy) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Glaucoma 01/2022
1	Brain Ischemia (Cerebral Ischemia) 01/2021
1	Ischemic Stroke 01/2021
1	Ischemia 01/2021
1	Reperfusion Injury 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2020
1	COVID-19 07/2020
1	Anemia 01/2020
1	Hemorrhage 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 05/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Diverticulum 01/2017
1	Melanoma (Melanoma, Malignant) 11/2015

Drug/Important Bio-Agent (IBA)

2	3- ((1- (dimethylamino)propan- 2- yl)oxy)- 5- ((4- methoxy- 5- (1- methyl- 1H- pyrazol- 4- yl)pyridin- 2- yl)amino)pyrazine- 2- carbonitrileIBA 01/2017 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 01/2016
1	Biological ProductsIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021
1	PlatinumIBA 12/2021
1	Beclin-1IBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 07/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	nintedanibIBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	afliberceptIBA 05/2019
1	Poly AIBA 01/2019
1	AntigensIBA 01/2019
1	cibisatamabIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	trametinibIBA 11/2015

Therapy/Procedure

4	Therapeutics 01/2022 - 07/2020
4	Radiotherapy 01/2017 - 11/2015
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2017
2	Chemoradiotherapy 01/2017 - 01/2016
1	Meditation 01/2022
1	Immunotherapy 01/2019
1	Stents 01/2017